Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation
- PMID: 30921344
- PMCID: PMC6438565
- DOI: 10.1371/journal.pone.0213866
Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation
Abstract
Infectious laryngotracheitis (ILT) is a respiratory disease that affects chickens. It is caused by the alphaherpesvirus, infectious laryngotracheitis virus (ILTV). This virus undergoes lytic replication in the epithelial cells of the trachea and upper respiratory tract (URT) and establishes latent infection in the trigeminal ganglia (TG) and trachea. Live attenuated vaccines are widely used to control ILT. At least one of these vaccines can establish latent infections in chickens, but this has not been demonstrated for all vaccines. The aim of the current study was to determine the capacity of three commercially available vaccines (SA2, A20 and Serva) and a glycoprotein G deletion mutant vaccine candidate (ΔgG ILTV) to establish latent infection in the TG of specific pathogen free (SPF) chickens. Five groups of 7-day-old SPF chickens were eye-drop vaccinated with either one of the vaccine strains or mock-vaccinated with sterile media and followed until 20 or 21 days post-vaccination (dpv). ILTV DNA was detected at 20-21 dpv in the TG of 23/40 (57.5%) vaccinated SPF chickens (SA2 = 10/10; A20 = 6/10; Serva = 3/10; ΔgG = 4/10) by PCR, but virus could not be reactivated from TG co-cultivated with primary chicken embryo kidney cells. In the birds from which ILTV DNA was detected in the TG, ILTV DNA could not be detected in the URT or trachea of 3 birds in each of the SA2, A20 and Serva vaccinated groups, and in 4 birds in the ΔgG vaccinated group, indicating that these birds were latently infected in the absence of active lytic replication and virus shedding. Results from this study demonstrate the capacity of commercial ILTV vaccines to establish latent infections and underline their importance in the epidemiology of this disease.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.Avian Pathol. 2011 Aug;40(4):411-7. doi: 10.1080/03079457.2011.588686. Avian Pathol. 2011. PMID: 21812721
-
Latency characteristics in specific pathogen-free chickens 21 and 35 days after intra-tracheal inoculation with vaccine or field strains of infectious laryngotracheitis virus.Avian Pathol. 2020 Aug;49(4):369-379. doi: 10.1080/03079457.2020.1754331. Epub 2020 Jun 2. Avian Pathol. 2020. PMID: 32352307
-
Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction-restriction fragment length polymorphism.Avian Dis. 2003 Apr-Jun;47(2):261-71. doi: 10.1637/0005-2086(2003)047[0261:EOLVVA]2.0.CO;2. Avian Dis. 2003. PMID: 12887186 Clinical Trial.
-
Immune responses to infectious laryngotracheitis virus.Dev Comp Immunol. 2013 Nov;41(3):454-62. doi: 10.1016/j.dci.2013.03.022. Epub 2013 Apr 6. Dev Comp Immunol. 2013. PMID: 23567343 Review.
-
The route of inoculation dictates the replication patterns of the infectious laryngotracheitis virus (ILTV) pathogenic strain and chicken embryo origin (CEO) vaccine.Avian Pathol. 2017 Dec;46(6):585-593. doi: 10.1080/03079457.2017.1331029. Epub 2017 Jun 19. Avian Pathol. 2017. PMID: 28532159 Review.
Cited by
-
Clinical assessment and transcriptome analysis of host immune responses in a vaccination-challenge study using a glycoprotein G deletion mutant vaccine strain of infectious laryngotracheitis virus.Front Immunol. 2025 Jan 24;15:1458218. doi: 10.3389/fimmu.2024.1458218. eCollection 2024. Front Immunol. 2025. PMID: 39926602 Free PMC article.
-
Host-virus interactions during infection with a wild-type ILTV strain or a glycoprotein G deletion mutant ILTV vaccine strain in an ex vivo system.Microbiol Spectr. 2025 Feb 4;13(2):e0118324. doi: 10.1128/spectrum.01183-24. Epub 2025 Jan 13. Microbiol Spectr. 2025. PMID: 39804092 Free PMC article.
-
Infectious laryngotracheitis: an update on current approaches for prevention of an old disease.J Anim Sci. 2020 Aug 18;98(Suppl 1):S27-S35. doi: 10.1093/jas/skaa133. J Anim Sci. 2020. PMID: 32810247 Free PMC article. No abstract available.
-
Transcriptomic analyses of host-virus interactions during in vitro infection with wild-type and glycoprotein g-deficient (ΔgG) strains of ILTV in primary and continuous cell cultures.PLoS One. 2024 Oct 11;19(10):e0311874. doi: 10.1371/journal.pone.0311874. eCollection 2024. PLoS One. 2024. PMID: 39392810 Free PMC article.
-
P53 maintains gallid alpha herpesvirus 1 replication by direct regulation of nucleotide metabolism and ATP synthesis through its target genes.Front Microbiol. 2022 Nov 24;13:1044141. doi: 10.3389/fmicb.2022.1044141. eCollection 2022. Front Microbiol. 2022. PMID: 36504811 Free PMC article.
References
-
- Raggi L, Brownell J, Stewart G. Effects of infectious laryngotracheitis virus on egg production and quality. Poultry Science. 1961;40(1):134–40.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous